tradingkey.logo

Lifecore Biomedical Inc

LFCR
6.850USD
+0.230+3.47%
收盘 11/07, 16:00美东报价延迟15分钟
256.64M总市值
亏损市盈率 TTM

Lifecore Biomedical Inc

6.850
+0.230+3.47%

关于 Lifecore Biomedical Inc 公司

Lifecore Biomedical, Inc. 是一家完全一体化的合同开发和制造组织 (CDMO)。该公司为生物材料市场设计、开发、制造和销售差异化产品,并向合作伙伴授权技术应用。该公司在注射器和小瓶中无菌注射级药品的开发、灌装和完成方面提供高度差异化的能力。该公司参与制造散装药用级透明质酸钠 (HA),以及用于治疗一系列医疗状况和程序的注射产品的配制和灌装注射器和小瓶。该公司利用其发酵工艺和无菌配方和灌装专业知识来开发用于多种应用的基于 HA 的产品,并利用非 HA 设备和药物机会。

Lifecore Biomedical Inc简介

公司代码LFCR
公司名称Lifecore Biomedical Inc
上市日期Feb 15, 1996
CEOMr. Paul Josephs
员工数量406
证券类型Ordinary Share
年结日Feb 15
公司地址3515 Lyman Boulevard
城市CHASKA
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编55318
电话19523684300
网址https://www.lifecore.com/
公司代码LFCR
上市日期Feb 15, 1996
CEOMr. Paul Josephs

Lifecore Biomedical Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+75.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+30.44%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+13.25%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-89.22%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-44.27%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-100.00%
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ms. Stephanie Diaz
Ms. Stephanie Diaz
Investor Relations
Investor Relations
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Matthew Edward Korenberg
Mr. Matthew Edward Korenberg
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+75.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+30.44%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+13.25%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-89.22%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-44.27%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-100.00%

收入明细

单位: USD更新时间: 3月4日 周二
单位: USD更新时间: 3月4日 周二
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
地区USD
名称
营收
占比
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
其他
1.50M
5.43%
业务
地区
业务USD
名称
营收
占比
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%

股东统计

更新时间: 9月20日 周六
更新时间: 9月20日 周六
持股股东
股东类型
持股股东
持股股东
占比
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.83%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
其他
54.91%
持股股东
持股股东
占比
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.83%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
其他
54.91%
股东类型
持股股东
占比
Hedge Fund
30.47%
Investment Advisor
24.54%
Investment Advisor/Hedge Fund
18.34%
Individual Investor
1.85%
Research Firm
1.81%
Bank and Trust
0.12%
Private Equity
0.08%
Venture Capital
0.05%
Insurance Company
0.02%
其他
22.71%

机构持股

更新时间: 10月5日 周日
更新时间: 10月5日 周日
报告期
机构数
持股数
持股占比
持股变动
2025Q3
203
28.26M
75.43%
-694.17K
2025Q2
212
27.35M
73.90%
-2.82M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
2023Q2
237
20.72M
68.32%
-8.44M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Wynnefield Capital, Inc.
4.70M
9.16%
--
--
Jun 30, 2025
Legion Partners Asset Management, LLC
4.43M
8.63%
--
--
Jun 30, 2025
Greenhaven Road Investment Management, L.P.
3.69M
7.19%
+78.69K
+2.18%
Jun 30, 2025
325 Capital LLC
2.16M
4.21%
+1.00
+0.00%
Sep 02, 2025
Laughing Water Capital, LP
1.90M
3.7%
--
--
Sep 02, 2025
David Capital Partners, LLC
1.80M
3.51%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.72M
3.35%
+90.16K
+5.52%
Jun 30, 2025
The Vanguard Group, Inc.
1.61M
3.13%
+63.30K
+4.09%
Jun 30, 2025
Geode Capital Management, L.L.C.
775.49K
1.51%
+25.00K
+3.33%
Jun 30, 2025
GrizzlyRock Capital, LLC
734.53K
1.43%
+734.53K
--
Jun 30, 2025
查看更多

持股ETF

更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
iShares Micro-Cap ETF
0.04%
WisdomTree US SmallCap Fund
0.03%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Motley Fool Next Index ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Value ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.04%
WisdomTree US SmallCap Fund
占比0.03%
Global X Russell 2000 ETF
占比0.01%
iShares Russell 2000 ETF
占比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
Motley Fool Next Index ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
iShares Russell 2000 Value ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
KeyAI